Home › Steatotic Liver Disease
Pag-aaral pangklinika para sa Steatotic Liver Disease na nagre-recruit sa U.S.
61 pag-aaral para sa Steatotic Liver Disease ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Miami, FL17 pag-aaral
- San Antonio, TX16 pag-aaral
- New York City, NY16 pag-aaral
- Houston, TX14 pag-aaral
- Austin, TX13 pag-aaral
- San Diego, CA12 pag-aaral
- Hialeah, FL11 pag-aaral
- Richmond, VA11 pag-aaral
- New Orleans, LA10 pag-aaral
- Orlando, FL10 pag-aaral
- Tucson, AZ10 pag-aaral
- Cape Coral, FL9 pag-aaral
- Dallas, TX9 pag-aaral
- Chandler, AZ9 pag-aaral
- Dayton, OH8 pag-aaral
- Topeka, KS8 pag-aaral
- Waco, TX8 pag-aaral
- Ocala, FL8 pag-aaral
- Los Angeles, CA8 pag-aaral
- St. Louis, MO8 pag-aaral
- Pasadena, CA8 pag-aaral
- Round Rock, TX8 pag-aaral
- Durham, NC8 pag-aaral
- Little Rock, AR8 pag-aaral
- Parma, OH8 pag-aaral
- Brownsville, TX7 pag-aaral
- Sugar Land, TX7 pag-aaral
- Seattle, WA7 pag-aaral
- Doral, FL7 pag-aaral
- Akron, OH7 pag-aaral
- Rochester, MN7 pag-aaral
- Arlington, TX7 pag-aaral
- Washington, DC7 pag-aaral
- Las Vegas, NV7 pag-aaral
- Sandy Springs, GA7 pag-aaral
- Havelock, NC6 pag-aaral
- Sarasota, FL6 pag-aaral
- Homestead, FL6 pag-aaral
- Indianapolis, IN6 pag-aaral
- Fayetteville, NC6 pag-aaral
Ayos sa estado
- Alabama4 pag-aaral
- Arizona14 pag-aaral
- Arkansas8 pag-aaral
- California21 pag-aaral
- Colorado5 pag-aaral
- Connecticut5 pag-aaral
- Florida21 pag-aaral
- Georgia8 pag-aaral
- Illinois7 pag-aaral
- Indiana8 pag-aaral
- Iowa4 pag-aaral
- Kansas8 pag-aaral
- Kentucky4 pag-aaral
- Louisiana12 pag-aaral
- Maryland8 pag-aaral
- Massachusetts9 pag-aaral
- Michigan8 pag-aaral
- Minnesota8 pag-aaral
- Mississippi4 pag-aaral
- Missouri13 pag-aaral
- Nevada7 pag-aaral
- New Jersey6 pag-aaral
- New Mexico3 pag-aaral
- New York17 pag-aaral
- North Carolina14 pag-aaral
- Ohio15 pag-aaral
- Pennsylvania5 pag-aaral
- Rhode Island3 pag-aaral
- South Carolina5 pag-aaral
- Tennessee9 pag-aaral
- Texas20 pag-aaral
- Utah7 pag-aaral
- Virginia15 pag-aaral
- Washington7 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06613698A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06528314Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07631637A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07288138NAFLD Clinical Care Pathway
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06671886Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07854782A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06920043A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07701993A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07358546Early Tracking of Childhood Health Determinants (ETCHED) Study
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Day – 99 Years · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT03481829Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT03884075Evaluation of Non-Invasive Tests for Metabolic Liver Disease
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07122700A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT06318169Blood Collection Biorepository for Liver Disease Research
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 7 pataas · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT03025074A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT07165028A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07527910Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05832229Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
Nagre-recruitPhase 2
Edad 5 hanggang 16 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06133101A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07221188Human Models of Selective Insulin Resistance: Alpelisib, Part I
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT06354088InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05463796Quantifying Hepatic Mitochondrial Fluxes in Humans
Nagre-recruitPhase 4
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05305287Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 25 hanggang 55 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT06993454Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.